BlackRock
NUTX

BlackRock’s Nutex Health NUTX Stock Holding History

BlackRock’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.6M Buy
407,349
+27,994
+7% +$3.55M ﹤0.01% 2456
2026
Q1 		$36.1M Buy
379,355
+97,802
+35% +$12M ﹤0.01% 2725
2025
Q4 		$46.3M Buy
281,553
+19,175
+7% +$2.54M ﹤0.01% 2565
2025
Q3 		$27.1M Buy
262,378
+14,431
+6% +$1.42M ﹤0.01% 2901
2025
Q2 		$30.9M Buy
247,947
+210,939
+570% +$27.2M ﹤0.01% 2765
2025
Q1 		$1.74M Buy
37,008
+6,267
+20% +$306K ﹤0.01% 4033
2024
Q4 		$974K Hold
30,741
– – ﹤0.01% 4229
2024
Q3 		$667K Buy
30,741
+1
+0% +$14 ﹤0.01% 4261
2024
Q2 		$183K Hold
30,740
– – ﹤0.01% 4567
2024
Q1 		$442K Hold
30,740
– – ﹤0.01% 4400
2023
Q4 		$830K Sell
30,740
-4,170
-12% -$130K ﹤0.01% 4307
2023
Q3 		$1.06M Buy
34,910
+30,671
+724% +$1.48M ﹤0.01% 4223
2023
Q2 		$268K Sell
4,239
-75,200
-95% -$6.45M ﹤0.01% 4659
2023
Q1 		$12M Buy
79,439
+2,702
+4% +$547K ﹤0.01% 3219
2022
Q4 		$21.9M Buy
76,737
+65,814
+603% +$12.6M ﹤0.01% 2987
2022
Q3 		$2.46M Sell
10,923
-159
-1% -$67.5K ﹤0.01% 4081
2022
Q2 		$5.36M Buy
+11,082
New +$13.1M ﹤0.01% 3788

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock's NUTX Position: Q2 2026 in Review

BlackRock increased its Nutex Health (NUTX) stake by 7.4% in Q2 2026, buying an estimated $3.55M and bringing the position to 407,349 shares worth $69.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

BlackRock first reported a position in NUTX in Q2 2022 and has held it in 17 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • BlackRock held 407,349 shares of Nutex Health worth $69.6M as of Q2 2026.
  • BlackRock bought 27,994 Nutex Health shares in Q2 2026, an estimated $3.55M.
  • Nutex Health made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2456 holding.
  • BlackRock first reported a position in Nutex Health in Q2 2022 and has held it in 17 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.